Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.915 USD | +8.81% | -3.28% | -86.99% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.99% | 120M | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
+56.46% | 25.23B | |
-15.06% | 15.36B | |
-9.14% | 11.95B | |
-16.63% | 11.6B | |
-43.00% | 11.51B | |
+6.37% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Top Midday Decliners